NCT04821921View on ClinicalTrials.gov

The Impact of the COVID-19 Pandemic on Diabetes Management

CompletedOBSERVATIONAL
Enrollment

1,503

Participants

Timeline

Start Date

April 9, 2021

Primary Completion Date

September 15, 2022

Study Completion Date

September 15, 2022

Conditions
Type 2 DiabetesType 1 Diabetes Mellitus
Interventions
OTHER

No intervention

Care as usual

Trial Locations (1)

20246

Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf, Hamburg

All Listed Sponsors
lead

Universitätsklinikum Hamburg-Eppendorf

OTHER